Skip to main content
. 2021 Jul 5;2021:7252280. doi: 10.1155/2021/7252280

Table 1.

Comparison of characteristics of patients with and without mortality in the cohort.

Variables Total (n = 656) Survival (n = 565) Death (n = 91) P value
Demographic characteristics
 Sex, n (%) 0.008
  Female 107 (16) 83 (15) 24 (26)
  Male 549 (84) 482 (85) 67 (74)
 Age, y 64.00 (52, 74) 63.00 (51, 73) 70.00 (59, 78) <0.001
 Smoking, n (%) 453 (69) 396 (70) 57 (63) 0.192
 Weekend on admission, n (%) 248 (38) 205 (36) 43 (47) 0.059
 Delay, n (%) 167 (25) 133 (24) 34 (37) 0.007
Vascular risk factors
 Hypertension, n (%) 380 (58) 326 (58) 54 (59) 0.857
 Diabetes mellitus, n (%) 121 (18) 98 (17) 23 (25) 0.096
 Prior-stroke, n (%) 35 (5) 30 (5) 5 (5) 1
 CKD, n (%) 152 (23) 122 (22) 30 (33) 0.024
Clinical data
 HR, beats/min 80 (72, 92) 80.00 (72, 91) 85 (73, 106) 0.003
 SBP, mmHg 124 (108, 140) 127 (110, 143) 111 (92, 129) <0.001
 DBP, mmHg 80 (68, 91) 80 (70, 92) 74 (58, 85) <0.001
 Shock_index 0.65 (0.55, 0.77) 0.64 (0.54, 0.75) 0.75 (0.61, 1.04) <0.001
Electrocardiographic data
 Inferior, n (%) 300 (46) 263 (47) 37 (41) 0.351
 Anterior, n (%) 322 (49) 276 (49) 46 (51) 0.851
 Other, n (%) 21 (3) 16 (3) 5 (5) 0.194
 Right ventricular, n (%) 7 (1) 6 (1) 1 (1) 1
Laboratory examinations on admission
 WBC, 109/L 11.27 (8.60, 14.19) 10.97 (8.34, 13.57) 13.92 (10.56, 19.51) <0.001
 Neutrophil count, 109/L 8.85 (6.34, 11.83) 8.46 (6.11, 11.19) 11.40 (8.43, 16.26) <0.001
 NLR 6.65 (3.89, 10.77) 6.25 (3.78, 9.85) 9.74 (5.89, 14.93) <0.001
 PLR 149.03 (104.31, 224.60) 148.96 (107.43, 220.27) 151.40 (81.96, 250.07) 0.518
 MLR 0.54 (0.37, 0.82) 0.51 (0.36, 0.76) 0.75 (0.41, 1.12) <0.001
 SIRI 4.51 (2.63, 8.44) 4.19 (2.47, 7.39) 8.41 (4.38, 15.27) <0.001
 SII 1285.43 (746.84, 2247.28) 1233.05 (735.30, 2139.17) 1923.99 (894.50, 2898.80) 0.003
 HB, g/L 139.00 (123.00, 154.00) 140.00 (124.00, 155.00) 128.00 (115.00, 147.00) 0.001
 RBC, 1012/L 4.54 (3.98, 5.01) 4.58 (4.05, 5.02) 4.21 (3.71, 4.88) 0.006
 PLT, 109/L 205.00 (161.00, 249.25) 207.00 (164.00, 250.00) 196.00 (138.00, 246.50) 0.113
 ALT, U/L 33.00 (23.00, 56.00) 32.00 (22.25, 51.75) 56.00 (30.00, 193.00) <0.001
 AST, U/L 72.00 (36.50, 169.5) 67.00 (35.00, 143.00) 225.00 (73.50, 456.00) <0.001
 GGT, U/L 44.00 (27.00, 75.00) 43.00 (27.00, 72.75) 61.00 (29.00, 104.00) 0.007
 BUN, mmol/L 6.72 (5.25, 9.37) 6.38 (5.09, 8.50) 10.33 (7.45, 13.15) <0.001
 Creatinine, umol/L 101.00 (82.00, 128.00) 98.00 (81.00, 119.00) 134.00 (109.00, 174.50) <0.001
 Uric acid, umol/L 484.00 (449.00, 542.00) 481.00 (447.00, 535.00) 523.00 (461.00, 637.00) <0.001
 Cystatin C, mg/L 1.22 (0.97, 1.58) 1.17 (0.95, 1.49) 1.65 (1.32, 2.18) <0.001
 CK, U/L 507.00 (186.00, 1368.75) 463.50 (172.00, 1322.50) 745.00 (303.25, 2012.50) 0.002
 CKMB, U/L 52.00 (25.00, 127.00) 48.00 (24.00, 117.25) 86.00 (33.00, 190.00) <0.001
 LDH, U/L 375.00 (266.25, 639.75) 350.50 (255.25, 556.75) 695.50 (407.75, 1229.75) <0.001
α-HBDH, U/L 259.00 (173.00, 475.00) 240.00 (165.00, 427.50) 490.50 (273.75, 773.00) <0.001
 CTnT, ng/L 1014.00 (213.50, 3480.00) 786.95 (185.97, 3069.00) 3077.00 (1133.00, 6711.00) <0.001
 BNP, pg/mL 1022.50 (255.15, 3860.75) 884.90 (204.85, 2713.00) 5349.00 (2058.00, 15267.00) <0.001
 Glucose, mmol/L 6.66 (5.56, 8.66) 6.52 (5.44, 8.19) 8.47 (6.41, 11.60) <0.001
 Myoglobin, ng/mL 341.10 (104.50, 910.40) 308.95 (95.96, 820.28) 615.00 (203.50, 2251.00) <0.001
Diseased vessel identified during procedure
 LM, n (%) 13 (2) 13 (2) 0 (0) 0.233
 LAD, n (%) 213 (33) 185 (33) 28 (31) 0.836
 LCX, n (%) 70 (11) 62 (11) 8 (9) 0.674
 RCA, n (%) 157 (24) 134 (24) 23 (26) 0.819
Risk assessment
 GRACE, score 125.00 (102.00, 154.00) 121.00 (101.00, 146.00) 178.00 (140.00, 206.50) <0.001

Values are expressed as medians with interquartile ranges for continuous data. Other values are presented as numbers and percentages. Shock index: ratio of HR to SBP; SIRI: systemic inflammatory response index; SII: systemic inflammatory reaction index; PLR: ratio of platelets to lymphocytes; NLR: the ratio of neutrophils to lymphocytes; MLR: ratio of monocytes to lymphocytes; OHCA: out-of-hospital cardiac arrest; GRACE: Global Registry of Acute Coronary Events score; α-HBDH: α-hydroxybutyrate dehydrogenase; BNP: B-type natriuretic peptides.